why choose us

First received: November 04, 2022

Clinical Trial: Safety and Efficacy of Faricimab in Patients With NPDR

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Non-Proliferative Diabetic Retinopathy

Study Type: INTERVENTIONAL


Official Title: Faricimab for Retinal Non-Perfusion Associated With Non-Proliferative Diabetic Retinopathy: The MAGIC Phase 2, Multi-Center, Open-Label, Randomized Controlled Trial

Brief Summary: The purpose of this Phase 2 study is comprised of two groups to evaluate the safety, tolerability, and efficacy of faricimab in patients with Non-Proliferative Diabetic Retinopathy.

Read more